Exploring the mechanisms of action of Cordyceps sinensis for the treatment of depression using network pharmacology and molecular docking

Xingfang Zhang, Mengyuan Wang, Yajun Qiao, Zhongshu Shan, Mengmeng Yang, Guoqiang Li, Yuancan Xiao, Lixin Wei, Hongtao Bi, Tingting Gao

Annals of Translational Medicine · 2022 · 18 citations · 35 references

DOIFull text

Open access

Abstract

The active ingredients of <i>Cordyceps</i> <i>sinensis</i> may exert antidepressant effects by regulating the CREB binding protein and anti-oxidative stress effects. The <i>foxo</i> signaling pathway (hsa04068), hypoxia-inducible factor 1 (HIF-1) signaling pathway (hsa04066), and Huntington's disease (hsa05016) may be involved in the underlying mechanisms of <i>Cordyceps</i> <i>sinensis</i>. The joint application of network pharmacology and molecular docking provides a new approach to study the mechanisms of action of traditional Chinese medicine. <i>Cordyceps sinensis</i> may play an important role in the future treatment of patients with depression.

References

35